EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinie

A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT)

Vera Domingos, Katerina Nezvalova-Henriksen, Adrin Dadkhah, Maria-Estela Moreno-Martinez, Khalil Ben Hassine, Vera Pires, Nicolaus Kröger, Tiene Bauters, Moustapha Hassan, Nick Duncan, Krzysztof Kalwak, Marc Ansari und 2 weitere

Bone Marrow Transplantation · 2024

DOI: 10.1038/s41409-024-02413-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bone Marrow Transplantation, 2024. Verfasst von Vera Domingos und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal. Hauptthemen laut MEDLINE: Busulfan, Drug Monitoring, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 136 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Busulfan (Bu) is an important component of many conditioning regimens for allogeneic hematopoietic cell transplantation. The therapeutic window of Bu is well characterized, with strong associations between Bu exposure and the clinical outcome in adults (strongest evidence in myelo-ablative setting) and children (all settings). We provide an overview of the literature on Bu as well as a step-by-step guide to the implementation of Bu therapeutic drug monitoring (TDM). The guide covers the clinical, pharmacological, laboratory and administrative aspects of the procedure. Through this document, we aim to support centers in implementing TDM for Bu to further enhance the success rates of HCT and improve patient outcomes. The Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT) encourages all centers to perform TDM for Bu in the aforementioned indications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BusulfanDrug MonitoringHematopoietic Stem Cell TransplantationHumansEuropeTransplantation ConditioningChildAdultSocieties, MedicalPharmacists

Substanzen

Busulfan

Autor:innen und Institutionen

  • Department of Pharmacy, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.
  • Department of Haematology, Oslo University Hospital, Oslo, Norway.
  • Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Hospital Pharmacy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Pharmacy Department, Hospital de la Santa Creu I Sant Pau, IIB Sant Pau, Barcelona, Spain.
  • School of Health Sciences Blanquerna, University Ramon Lull, Barcelona, Spain.

Zitieren

APA

Domingos, V., Nezvalova-Henriksen, K., Dadkhah, A., Moreno-Martinez, M. E., Ben Hassine, K., Pires, V., Kröger, N., Bauters, T., Hassan, M., Duncan, N., Kalwak, K., Ansari, M., Langebrake, C., & Admiraal, R. (2024). A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. https://doi.org/10.1038/s41409-024-02413-0

Vancouver

Domingos V, Nezvalova-Henriksen K, Dadkhah A, Moreno-Martinez ME, Ben Hassine K, Pires V, et al. A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 2024. doi:10.1038/s41409-024-02413-0

BibTeX
@article{Domingos2024,
  author = {Domingos, Vera and Nezvalova-Henriksen, Katerina and Dadkhah, Adrin and Moreno-Martinez, Maria-Estela and Ben Hassine, Khalil and Pires, Vera and Kröger, Nicolaus and Bauters, Tiene and Hassan, Moustapha and Duncan, Nick and Kalwak, Krzysztof and Ansari, Marc and Langebrake, Claudia and Admiraal, Rick},
  title = {A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT)},
  journal = {Bone Marrow Transplantation},
  year = {2024},
  doi = {10.1038/s41409-024-02413-0}
}
Kostenlos starten →